| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB6
|
ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group)
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABHD12
|
abhydrolase domain containing 12
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACADVL
|
acyl-CoA dehydrogenase, very long chain
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ACTG1
|
actin gamma 1
|
|
ACVR2A
|
activin A receptor, type IIA
|
|
ADA
|
adenosine deaminase
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAMTS8
|
ADAM metallopeptidase with thrombospondin type 1 motif, 8
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADM
|
adrenomedullin
|
|
AFP
|
alpha-fetoprotein
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AHI1
|
Abelson helper integration site 1
|
|
AIM2
|
absent in melanoma 2
|
|
AIRE
|
autoimmune regulator
|
|
AK1
|
adenylate kinase 1
|
|
AKAP12
|
A kinase (PRKA) anchor protein 12
|
|
AKR7A2
|
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALDH1A3
|
aldehyde dehydrogenase 1 family, member A3
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALG6
|
ALG6, alpha-1,3-glucosyltransferase
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
AMER1
|
APC membrane recruitment protein 1
|
|
ANKRD30A
|
ankyrin repeat domain 30A
|
|
ANOS1
|
anosmin 1
|
|
ANXA1
|
annexin A1
|
|
AP2S1
|
adaptor-related protein complex 2, sigma 1 subunit
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARMC5
|
armadillo repeat containing 5
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ASL
|
argininosuccinate lyase
|
|
ASMT
|
acetylserotonin O-methyltransferase
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide
|
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
ATXN1
|
ataxin 1
|
|
ATXN3
|
ataxin 3
|
|
AURKA
|
aurora kinase A
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
AZF1
|
azoospermia factor 1
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L10
|
BCL2-like 10 (apoptosis facilitator)
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BEST1
|
bestrophin 1
|
|
BIN1
|
bridging integrator 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BLID
|
BH3-like motif containing, cell death inducer
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BLNK
|
B-cell linker
|
|
BMP3
|
bone morphogenetic protein 3
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRINP1
|
bone morphogenetic protein/retinoic acid inducible neural-specific 1
|
|
BTBD9
|
BTB (POZ) domain containing 9
|
|
BTG4
|
B-cell translocation gene 4
|
|
BVES
|
blood vessel epicardial substance
|
|
C2
|
complement component 2
|
|
C20ORF85
|
chromosome 20 open reading frame 85
|
|
C2ORF40
|
chromosome 2 open reading frame 40
|
|
C3
|
complement component 3
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CADM1
|
cell adhesion molecule 1
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALCRL
|
calcitonin receptor-like
|
|
CALR
|
calreticulin
|
|
CAPN3
|
calpain 3, (p94)
|
|
CASK
|
calcium/calmodulin-dependent serine protein kinase (MAGUK family)
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV2
|
caveolin 2
|
|
CAV3
|
caveolin 3
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCL4L1
|
chemokine (C-C motif) ligand 4-like 1
|
|
CCL4L2
|
chemokine (C-C motif) ligand 4-like 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCNE1
|
cyclin E1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD34
|
CD34 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD81
|
CD81 molecule
|
|
CD82
|
CD82 molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDH13
|
cadherin 13
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEP290
|
centrosomal protein 290kDa
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CHGA
|
chromogranin A
|
|
CHKA
|
choline kinase alpha
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CLDN1
|
claudin 1
|
|
CMTM5
|
CKLF-like MARVEL transmembrane domain containing 5
|
|
CNGA3
|
cyclic nucleotide gated channel alpha 3
|
|
CNGB3
|
cyclic nucleotide gated channel beta 3
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL7A1
|
collagen, type VII, alpha 1
|
|
COL9A2
|
collagen, type IX, alpha 2
|
|
COMT
|
catechol-O-methyltransferase
|
|
COX17
|
COX17 cytochrome c oxidase copper chaperone
|
|
CRABP1
|
cellular retinoic acid binding protein 1
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSAG2
|
CSAG family, member 2
|
|
CST6
|
cystatin E/M
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTDSPL
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CUL1
|
cullin 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP46A1
|
cytochrome P450, family 46, subfamily A, polypeptide 1
|
|
CYP4V2
|
cytochrome P450, family 4, subfamily V, polypeptide 2
|
|
CYP7B1
|
cytochrome P450, family 7, subfamily B, polypeptide 1
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAPK2
|
death-associated protein kinase 2
|
|
DAZ1
|
deleted in azoospermia 1
|
|
DCBLD2
|
discoidin, CUB and LCCL domain containing 2
|
|
DCC
|
DCC netrin 1 receptor
|
|
DDX43
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 43
|
|
DDX56
|
DEAD (Asp-Glu-Ala-Asp) box helicase 56
|
|
DEK
|
DEK proto-oncogene
|
|
DES
|
desmin
|
|
DHCR7
|
7-dehydrocholesterol reductase
|
|
DKC1
|
dyskeratosis congenita 1, dyskerin
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLEC1
|
deleted in lung and esophageal cancer 1
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DOC2B
|
double C2-like domains, beta
|
|
DPY19L2
|
dpy-19-like 2 (C. elegans)
|
|
DRD1
|
dopamine receptor D1
|
|
DRD4
|
dopamine receptor D4
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
DUOX1
|
dual oxidase 1
|
|
DUOX2
|
dual oxidase 2
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F4
|
E2F transcription factor 4, p107/p130-binding
|
|
EBF3
|
early B-cell factor 3
|
|
EDA2R
|
ectodysplasin A2 receptor
|
|
EDARADD
|
EDAR-associated death domain
|
|
EDNRB
|
endothelin receptor type B
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific )
|
|
EML4
|
echinoderm microtubule associated protein like 4
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA1
|
EPH receptor A1
|
|
EPHB2
|
EPH receptor B2
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETV3
|
ets variant 3
|
|
ETV6
|
ets variant 6
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FH
|
fumarate hydratase
|
|
FHIT
|
fragile histidine triad
|
|
FKBP5
|
FK506 binding protein 5
|
|
FKRP
|
fukutin related protein
|
|
FLG
|
filaggrin
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOXC2
|
forkhead box C2
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FTO
|
fat mass and obesity associated
|
|
FUBP1
|
far upstream element (FUSE) binding protein 1
|
|
FUS
|
FUS RNA binding protein
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GALC
|
galactosylceramidase
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GATA4
|
GATA binding protein 4
|
|
GATA5
|
GATA binding protein 5
|
|
GBA
|
glucosidase, beta, acid
|
|
GBA2
|
glucosidase, beta (bile acid) 2
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GDAP1
|
ganglioside induced differentiation associated protein 1
|
|
GDF10
|
growth differentiation factor 10
|
|
GH1
|
growth hormone 1
|
|
GIGYF2
|
GRB10 interacting GYF protein 2
|
|
GJA5
|
gap junction protein, alpha 5, 40kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLTSCR2
|
glioma tumor suppressor candidate region gene 2
|
|
GLUD1
|
glutamate dehydrogenase 1
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAS
|
GNAS complex locus
|
|
GNG7
|
guanine nucleotide binding protein (G protein), gamma 7
|
|
GOT1
|
glutamic-oxaloacetic transaminase 1, soluble
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GPC3
|
glypican 3
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
GRN
|
granulin
|
|
GSN
|
gelsolin
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM3
|
glutathione S-transferase mu 3 (brain)
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
H3F3A
|
H3 histone, family 3A
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAND1
|
heart and neural crest derivatives expressed 1
|
|
HAS1
|
hyaluronan synthase 1
|
|
HBA2
|
hemoglobin, alpha 2
|
|
HBB
|
hemoglobin, beta
|
|
HDAC11
|
histone deacetylase 11
|
|
HDAC2
|
histone deacetylase 2
|
|
HFE
|
hemochromatosis
|
|
HFE2
|
hemochromatosis type 2 (juvenile)
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HIST1H3B
|
histone cluster 1, H3b
|
|
HK1
|
hexokinase 1
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DMA
|
major histocompatibility complex, class II, DM alpha
|
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HMBS
|
hydroxymethylbilane synthase
|
|
HNF1A
|
HNF1 homeobox A
|
|
HOPX
|
HOP homeobox
|
|
HOXA9
|
homeobox A9
|
|
HOXB13
|
homeobox B13
|
|
HP
|
haptoglobin
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IGH
|
immunoglobulin heavy locus
|
|
IL10
|
interleukin 10
|
|
IL12B
|
interleukin 12B
|
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IMPDH1
|
IMP (inosine 5'-monophosphate) dehydrogenase 1
|
|
IMPDH2
|
IMP (inosine 5'-monophosphate) dehydrogenase 2
|
|
ING4
|
inhibitor of growth family, member 4
|
|
INSIG2
|
insulin induced gene 2
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF6
|
interferon regulatory factor 6
|
|
IRX1
|
iroquois homeobox 1
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITIH1
|
inter-alpha-trypsin inhibitor heavy chain 1
|
|
JAK2
|
Janus kinase 2
|
|
JARID2
|
jumonji, AT rich interactive domain 2
|
|
JAZF1
|
JAZF zinc finger 1
|
|
KCND2
|
potassium channel, voltage gated Shal related subfamily D, member 2
|
|
KCND3
|
potassium channel, voltage gated Shal related subfamily D, member 3
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KHSRP
|
KH-type splicing regulatory protein
|
|
KIF1A
|
kinesin family member 1A
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIR2DS5
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIR3DS1
|
killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KISS1R
|
KISS1 receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF11
|
Kruppel-like factor 11
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLHL40
|
kelch-like family member 40
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT7
|
keratin 7, type II
|
|
L1RE1
|
LINE1 retrotransposable element 1
|
|
LCT
|
lactase
|
|
LDHB
|
lactate dehydrogenase B
|
|
LDLR
|
low density lipoprotein receptor
|
|
LDOC1
|
leucine zipper, down-regulated in cancer 1
|
|
LEP
|
leptin
|
|
LGI1
|
leucine-rich, glioma inactivated 1
|
|
LGI4
|
leucine-rich repeat LGI family, member 4
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
|
LHB
|
luteinizing hormone beta polypeptide
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LHX2
|
LIM homeobox 2
|
|
LITAF
|
lipopolysaccharide-induced TNF factor
|
|
LMAN1
|
lectin, mannose-binding, 1
|
|
LMNA
|
lamin A/C
|
|
LOXL2
|
lysyl oxidase-like 2
|
|
LPL
|
lipoprotein lipase
|
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1
|
|
LRP1B
|
low density lipoprotein receptor-related protein 1B
|
|
LRRC4
|
leucine rich repeat containing 4
|
|
LRRK1
|
leucine-rich repeat kinase 1
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTA
|
lymphotoxin alpha
|
|
LTC4S
|
leukotriene C4 synthase
|
|
LTF
|
lactotransferrin
|
|
LZTS1
|
leucine zipper, putative tumor suppressor 1
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MAML2
|
mastermind-like 2 (Drosophila)
|
|
MAN1B1
|
mannosidase, alpha, class 1B, member 1
|
|
MAP3K3
|
mitogen-activated protein kinase kinase kinase 3
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED12
|
mediator complex subunit 12
|
|
MEFV
|
Mediterranean fever
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFN2
|
mitofusin 2
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIR29A
|
microRNA 29a
|
|
MIR30A
|
microRNA 30a
|
|
MIR31
|
microRNA 31
|
|
MIR34B
|
microRNA 34b
|
|
MIR34C
|
microRNA 34c
|
|
MIR874
|
microRNA 874
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MMACHC
|
methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MORC3
|
MORC family CW-type zinc finger 3
|
|
MPG
|
N-methylpurine-DNA glycosylase
|
|
MPO
|
myeloperoxidase
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSH2
|
mutS homolog 2
|
|
MSH3
|
mutS homolog 3
|
|
MSH6
|
mutS homolog 6
|
|
MSMB
|
microseminoprotein, beta-
|
|
MT-ATP6
|
ATP synthase F0 subunit 6
|
|
MT1G
|
metallothionein 1G
|
|
MT3
|
metallothionein 3
|
|
MTA1
|
metastasis associated 1
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUT
|
methylmalonyl CoA mutase
|
|
MUTYH
|
mutY homolog
|
|
MVK
|
mevalonate kinase
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYO7A
|
myosin VIIA
|
|
MYO9B
|
myosin IXB
|
|
MYOCD
|
myocardin
|
|
MYOD1
|
myogenic differentiation 1
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NEUROD1
|
neuronal differentiation 1
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NIPBL
|
Nipped-B homolog (Drosophila)
|
|
NIT1
|
nitrilase 1
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NLRP7
|
NLR family, pyrin domain containing 7
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOTCH3
|
notch 3
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NPY1R
|
neuropeptide Y receptor Y1
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRXN1
|
neurexin 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
OSCP1
|
organic solute carrier partner 1
|
|
OTOF
|
otoferlin
|
|
PAH
|
phenylalanine hydroxylase
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARL
|
presenilin associated, rhomboid-like
|
|
PAX5
|
paired box 5
|
|
PAX6
|
paired box 6
|
|
PAX8
|
paired box 8
|
|
PBRM1
|
polybromo 1
|
|
PCDH10
|
protocadherin 10
|
|
PCDH11Y
|
protocadherin 11 Y-linked
|
|
PCDH19
|
protocadherin 19
|
|
PDE6B
|
phosphodiesterase 6B, cGMP-specific, rod, beta
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDHB
|
pyruvate dehydrogenase (lipoamide) beta
|
|
PDPN
|
podoplanin
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PEG3
|
paternally expressed 3
|
|
PER3
|
period circadian clock 3
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PIP
|
prolactin-induced protein
|
|
PITX1
|
paired-like homeodomain 1
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
|
PLN
|
phospholamban
|
|
PMP22
|
peripheral myelin protein 22
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
POLE
|
polymerase (DNA directed), epsilon, catalytic subunit
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
PON1
|
paraoxonase 1
|
|
POPDC3
|
popeye domain containing 3
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPP2R1A
|
protein phosphatase 2, regulatory subunit A, alpha
|
|
PPP2R1B
|
protein phosphatase 2, regulatory subunit A, beta
|
|
PQBP1
|
polyglutamine binding protein 1
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRDM5
|
PR domain containing 5
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRICKLE1
|
prickle homolog 1 (Drosophila)
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROM1
|
prominin 1
|
|
PROS1
|
protein S (alpha)
|
|
PRPH2
|
peripherin 2 (retinal degeneration, slow)
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
PRSS3
|
protease, serine, 3
|
|
PSEN1
|
presenilin 1
|
|
PSEN2
|
presenilin 2
|
|
PSMA6
|
proteasome (prosome, macropain) subunit, alpha type, 6
|
|
PSMC4
|
proteasome (prosome, macropain) 26S subunit, ATPase, 4
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
|
PTPRN
|
protein tyrosine phosphatase, receptor type, N
|
|
PVR
|
poliovirus receptor
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
|
PYCARD
|
PYD and CARD domain containing
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAI1
|
retinoic acid induced 1
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARRES1
|
retinoic acid receptor responder (tazarotene induced) 1
|
|
RASL10A
|
RAS-like, family 10, member A
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF10
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 10
|
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5
|
|
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6
|
|
RASSF7
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7
|
|
RAX
|
retina and anterior neural fold homeobox
|
|
RB1
|
retinoblastoma 1
|
|
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1
|
|
RECQL4
|
RecQ protein-like 4
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RGMA
|
repulsive guidance molecule family member a
|
|
RHCE
|
Rh blood group, CcEe antigens
|
|
RHD
|
Rh blood group, D antigen
|
|
RHO
|
rhodopsin
|
|
RHOBTB1
|
Rho-related BTB domain containing 1
|
|
RHOBTB2
|
Rho-related BTB domain containing 2
|
|
RHOC
|
ras homolog family member C
|
|
RIT1
|
Ras-like without CAAX 1
|
|
RLN2
|
relaxin 2
|
|
RPS27
|
ribosomal protein S27
|
|
RPS6KA6
|
ribosomal protein S6 kinase, 90kDa, polypeptide 6
|
|
RRM2
|
ribonucleotide reductase M2
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RXFP2
|
relaxin/insulin-like family peptide receptor 2
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
S100A2
|
S100 calcium binding protein A2
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SAG
|
S-antigen; retina and pineal gland (arrestin)
|
|
SAT1
|
spermidine/spermine N1-acetyltransferase 1
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SCGB3A1
|
secretoglobin, family 3A, member 1
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SELENBP1
|
selenium binding protein 1
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SETD5
|
SET domain containing 5
|
|
SETDB1
|
SET domain, bifurcated 1
|
|
SETX
|
senataxin
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFRP5
|
secreted frizzled-related protein 5
|
|
SFTPD
|
surfactant protein D
|
|
SH2D1A
|
SH2 domain containing 1A
|
|
SH3GL2
|
SH3-domain GRB2-like 2
|
|
SH3TC2
|
SH3 domain and tetratricopeptide repeats 2
|
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3
|
|
SHH
|
sonic hedgehog
|
|
SHMT1
|
serine hydroxymethyltransferase 1 (soluble)
|
|
SHOX
|
short stature homeobox
|
|
SHOX2
|
short stature homeobox 2
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter)
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC24A2
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 2
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A2
|
solute carrier family 2 (facilitated glucose transporter), member 2
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC37A4
|
solute carrier family 37 (glucose-6-phosphate transporter), member 4
|
|
SLC38A1
|
solute carrier family 38, member 1
|
|
SLC3A1
|
solute carrier family 3 (amino acid transporter heavy chain), member 1
|
|
SLC5A8
|
solute carrier family 5 (sodium/monocarboxylate cotransporter), member 8
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC7A4
|
solute carrier family 7, member 4
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMC2
|
structural maintenance of chromosomes 2
|
|
SMC4
|
structural maintenance of chromosomes 4
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMN2
|
survival of motor neuron 2, centromeric
|
|
SNAI1
|
snail family zinc finger 1
|
|
SOAT1
|
sterol O-acyltransferase 1
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOCS6
|
suppressor of cytokine signaling 6
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOX1
|
SRY (sex determining region Y)-box 1
|
|
SOX11
|
SRY (sex determining region Y)-box 11
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SPA17
|
sperm autoantigenic protein 17
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPAST
|
spastin
|
|
SPDEF
|
SAM pointed domain containing ETS transcription factor
|
|
SPG11
|
spastic paraplegia 11 (autosomal recessive)
|
|
SPG7
|
spastic paraplegia 7 (pure and complicated autosomal recessive)
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
|
SSPN
|
sarcospan
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STK11
|
serine/threonine kinase 11
|
|
SURF1
|
surfeit 1
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
|
SYK
|
spleen tyrosine kinase
|
|
SYNJ1
|
synaptojanin 1
|
|
TACR3
|
tachykinin receptor 3
|
|
TAF1
|
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa
|
|
TARDBP
|
TAR DNA binding protein
|
|
TARS
|
threonyl-tRNA synthetase
|
|
TAS1R1
|
taste receptor, type 1, member 1
|
|
TAS1R3
|
taste receptor, type 1, member 3
|
|
TCF21
|
transcription factor 21
|
|
TCF4
|
transcription factor 4
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET1
|
tet methylcytosine dioxygenase 1
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TH
|
tyrosine hydroxylase
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR9
|
toll-like receptor 9
|
|
TLX1
|
T-cell leukemia homeobox 1
|
|
TMLHE
|
trimethyllysine hydroxylase, epsilon
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP53BP2
|
tumor protein p53 binding protein 2
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPI1
|
triosephosphate isomerase 1
|
|
TPM2
|
tropomyosin 2 (beta)
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TPP1
|
tripeptidyl peptidase I
|
|
TRIM33
|
tripartite motif containing 33
|
|
TRIT1
|
tRNA isopentenyltransferase 1
|
|
TRPM6
|
transient receptor potential cation channel, subfamily M, member 6
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSHB
|
thyroid stimulating hormone, beta
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSPAN12
|
tetraspanin 12
|
|
TTR
|
transthyretin
|
|
TUBB1
|
tubulin, beta 1 class VI
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TWSG1
|
twisted gastrulation BMP signaling modulator 1
|
|
TYMS
|
thymidylate synthetase
|
|
TYR
|
tyrosinase
|
|
U2AF1
|
U2 small nuclear RNA auxiliary factor 1
|
|
UBQLN2
|
ubiquilin 2
|
|
UFD1L
|
ubiquitin fusion degradation 1 like (yeast)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6
|
|
UGT1A7
|
UDP glucuronosyltransferase 1 family, polypeptide A7
|
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9
|
|
UMODL1
|
uromodulin-like 1
|
|
UNC13D
|
unc-13 homolog D (C. elegans)
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VPS13B
|
vacuolar protein sorting 13 homolog B (yeast)
|
|
VPS26A
|
vacuolar protein sorting 26 homolog A (S. pombe)
|
|
VPS35
|
vacuolar protein sorting 35 homolog (S. cerevisiae)
|
|
VWF
|
von Willebrand factor
|
|
WDR11
|
WD repeat domain 11
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WRAP53
|
WD repeat containing, antisense to TP53
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XAF1
|
XIAP associated factor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
YWHAE
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
|
|
YY1
|
YY1 transcription factor
|
|
ZAR1
|
zygote arrest 1
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZFYVE26
|
zinc finger, FYVE domain containing 26
|
|
ZRSR2
|
zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2
|
